Similar Posts
Speaker: Big Data & Oncology
If there is one filed of Medicine where AI is already showing greatest impact is Oncology. Last Thursday I was at the Encontros da Primavera, in Évora, discussing the challenges of big data and examples of AI applications in Oncology, sharing the stage with Sofia Rocha. We had a lively discussion with an audience of…
Innovation Juri at the Faculty of Science
I had the pleasure to participate in a Juri for the first edition of the Internal Competition for Science Innovation Projects at the Faculty of Science, University of Lisbon, a process which concluded with a final event on January 18th. I’ve seen impressive projects and wish the best success to all the teams involved. The…
About HepatoPredict on HealthEuropa
I had the opportunity to answer some questions for Health Europa about a tool we are developing to help liver cancer paints in finding the best treatment, in particular to ascertain their eligibility for curative intent surgical treatments. HepatoPredict: stratifying liver cancer patients for transplantation
Biomarkers that predict Barrett’s oesophagus malignant progression
A new paper was just published by my Computational Genomics Group at the Instituto Gulbenkian de Ciência – CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett’s Esophagus Malignant Progression. This was a collaborative study with clinicians from the the Lisbon Cancer Centre (Instituto Portugues de Oncologia de Lisboa), funded by a grant…
Round table on Innovation on the 112th aniversary of the Faculty of Sciences
I had the privilege to participate in a round table about collaborations between academia and industry promoted by Tech Labs during the celebration of the University of Lisbon’s 112th anniversary. A panel of people with different backgrounds (VC, Corporate, Start Ups) had strikingly different views, which I guess promises diverse possibilities of making this collaboration…
Discussing Precision Medicine in Oncology
I presented the development of HepatoPredict and our experience of translating discoveries on biomarkers into clinically relevant ready to use products at the meeting Precision Medicine in Oncology In Porto. Thank you Nuno value for the invitation.